Search - tctmd.com

Displaying 581 - 600 of 1134

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Personalized Computational Modeling for Structural Heart Interventions

Presenter: Juan F. Granada, Martin B. Leon, Matthieu De Beule

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Minimizing Left Ventricular Outflow Tract Obstruction in Valve-in-Mitral Cases: A Novel Technique

Presenter: Juan F. Granada, Martin B. Leon, Tarek Helmy

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Early Clinical Experience With Hybrid Transcatheter Left Ventricular Reconstruction for the Treatment of Ischemic Heart Failure

Presenter: Patrick Klein

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

Presenter: Francesco Maisano

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device: The SAFE MANTA Study

Presenter: David A. Wood

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages

Presenter: David J. Cohen

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #2: Useful and Evolving Biomarkers in Aortic Stenosis and TAVR - Current Status and Future Directions

Presenter: Brian R Lindman

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #1: New AS Classification Scheme Based on Cardiac Damage - Changes After AVR

Presenter: Philippe Genereux

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Counterpoint: A "Selective" Minimalist Strategy Makes More Sense, and "Extreme" Minimalism Is Dangerous!

Presenter: Eberhard Grube, Howard C. Herrmann, Susheel K. Kodali

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Point: A Minimalist Strategy Should Be Used in ALL TAVR Patients!

Presenter: Eberhard Grube, Howard C. Herrmann, Vinod H. Thourani

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Early Results After TMVR for Mitral Annular Calcification

Presenter: Vinayak Bapat, John G. Webb, Mayra Guerrero

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Challenges to Transcatheter Mitral Valve Replacement: Lessons From the Early Feasibility Studies

Presenter: Vinayak Bapat, John G. Webb

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? YES!

Presenter: Scott Lim

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? NO!

Presenter: Francesco Maisano

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Can Transcatheter Mitral Rings, Edge-to-Edge, and Chords Match or Exceed Open Surgical Procedures? NO!

Presenter: Gilbert H.L. Tang

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Can Transcatheter Mitral Rings, Edge-to-Edge, and Chords Match or Exceed Open Surgical Procedures? YES!

Presenter: Ted Feldman

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

Presenter: Susheel K. Kodali, Michael J. Reardon, Patrick M. McCarthy

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Point: TAVR Will Be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

Presenter: Susheel K. Kodali, Michael J. Reardon, Mathew Williams

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Perspectives From the STS/ACC TVT Registry: Factors That Impact Clinical Outcomes

Presenter: Michael J. Mack, John D. Carroll

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

Presenter: Michael J. Mack, Bernard Prendergast

June 21, 2018

Advertisement

Personalized Computational Modeling for Structural Heart Interventions

Minimizing Left Ventricular Outflow Tract Obstruction in Valve-in-Mitral Cases: A Novel Technique

Early Clinical Experience With Hybrid Transcatheter Left Ventricular Reconstruction for the Treatment of Ischemic Heart Failure

Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device: The SAFE MANTA Study

Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages

Keynote Lecture #2: Useful and Evolving Biomarkers in Aortic Stenosis and TAVR - Current Status and Future Directions

Keynote Lecture #1: New AS Classification Scheme Based on Cardiac Damage - Changes After AVR

Counterpoint: A "Selective" Minimalist Strategy Makes More Sense, and "Extreme" Minimalism Is Dangerous!

Point: A Minimalist Strategy Should Be Used in ALL TAVR Patients!

Early Results After TMVR for Mitral Annular Calcification

Challenges to Transcatheter Mitral Valve Replacement: Lessons From the Early Feasibility Studies

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? YES!

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? NO!

Can Transcatheter Mitral Rings, Edge-to-Edge, and Chords Match or Exceed Open Surgical Procedures? NO!

Can Transcatheter Mitral Rings, Edge-to-Edge, and Chords Match or Exceed Open Surgical Procedures? YES!

Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

Point: TAVR Will Be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

Perspectives From the STS/ACC TVT Registry: Factors That Impact Clinical Outcomes

New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content